Loading clinical trials...
Loading clinical trials...
A Trial of Pembrolizumab in Combination With Doxorubicin as Treatment for Patients With Advanced Sarcomas
Conditions
Interventions
Doxorubicin Hydrochloride
Laboratory Biomarker Analysis
+1 more
Locations
1
United States
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States
Start Date
December 5, 2016
Primary Completion Date
March 17, 2020
Completion Date
October 9, 2020
Last Updated
May 26, 2021
NCT06926283
NCT07548177
NCT03050268
NCT06422806
NCT07467772
NCT05969860
Lead Sponsor
Fred Hutchinson Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions